SCOPUS 정보 검색 플랫폼

Nature Clinical Practice Oncology

Volumn 5, Issue 10, 2008, Pages 570-571

Choosing a taxane for adjuvant treatment of breast cancer: More than a flip of the coin?

(1) Vahdat, Linda a

a WEILL CORNELL MEDICAL COLLEGE (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; PACLITAXEL; TAXANE DERIVATIVE;

ADJUVANT THERAPY; BONE MARROW SUPPRESSION; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER SURVIVAL; CLINICAL TRIAL; DISEASE FREE SURVIVAL; DOSAGE SCHEDULE COMPARISON; DRUG DOSE REGIMEN; DRUG EFFICACY; FEBRILE NEUTROPENIA; GASTROINTESTINAL SYMPTOM; HIGH RISK PATIENT; HUMAN; INFECTION; LYMPH NODE METASTASIS; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; SHORT SURVEY; TREATMENT RESPONSE;

EID: 53749093221 PISSN: 17434254 EISSN: 17434262 Source Type: Journal
DOI: 10.1038/ncponc1215 Document Type: Short Survey

Times cited : (4)

References (7)

1
- 37849035252
- Taxane-based combinations as adjuvant chemotherapy of early breast cancer: A meta-analysis of randomized trials
- De Laurentiis M et al. (2008) Taxane-based combinations as adjuvant chemotherapy of early breast cancer: A meta-analysis of randomized trials. J Clin Oncol 26: 44-53
- (2008) J Clin Oncol , vol.26 , pp. 44-53
- De Laurentiis, M.¹

2
- 42249083269
- Weekly paclitaxel in the adjuvant treatment of breast cancer
- Sparano JA et al. (2008) Weekly paclitaxel in the adjuvant treatment of breast cancer. N Engl J Med 358: 1663-1671
- (2008) N Engl J Med , vol.358 , pp. 1663-1671
- Sparano, J.A.¹

3
- 35248895346
- HER2 and response to paclitaxel in node-positive breast cancer
- Hayes D et al. (2007) HER2 and response to paclitaxel in node-positive breast cancer. N Engl J Med 357: 1496-1506
- (2007) N Engl J Med , vol.357 , pp. 1496-1506
- Hayes, D.¹

4
- 33645729203
- Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer
- Berry DA et al. (2006) Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer. JAMA 295: 1658-1667
- (2006) JAMA , vol.295 , pp. 1658-1667
- Berry, D.A.¹

5
- 0037687355
- Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: First report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741
- Citron ML et al. (2003) Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: First report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741. J Clin Oncol 21: 1431-1439
- (2003) J Clin Oncol , vol.21 , pp. 1431-1439
- Citron, M.L.¹

6
- 33646495104
- Randomised trial: Survival benefit and safety of adjuvant dose-dense chemotherapy for node-positive breast cancer
- Kummel S et al. (2006) Randomised trial: Survival benefit and safety of adjuvant dose-dense chemotherapy for node-positive breast cancer. Br J Cancer 94: 1237-1244
- (2006) Br J Cancer , vol.94 , pp. 1237-1244
- Kummel, S.¹

7
- 43249085592
- Postoperative dose-dense sequential chemotherapy with epirubicin, paclitaxel and CMF in patients with high-risk breast cancer: Safety analysis of the Hellenic Cooperative Oncology Group randomized phase III trial HE 10/00
- Fountzilas G et al. (2008) Postoperative dose-dense sequential chemotherapy with epirubicin, paclitaxel and CMF in patients with high-risk breast cancer: Safety analysis of the Hellenic Cooperative Oncology Group randomized phase III trial HE 10/00. Ann Oncol 19: 853-860
- (2008) Ann Oncol , vol.19 , pp. 853-860
- Fountzilas, G.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.